Clinical practice guidelines for diagnosis and treatment membranous nephropathy

membranous nephropathy, minimal change disease, determination, classification, diagnostics, prophylactics, treatment

1. Аткинс РК. Гломерулонефриты. Нефрология и диализ 2000; 2 (4)

2. Захарова ЕВ. Роль циклоспорина в лечении идиопатического гломерулонефрита и волчаночного нефрита. Нефрология и диализ 2010; 12(2): 126-141

3. Козловская ЛВ. Хронический гломерулонефрит: аргументы в пользу циклоспорина. Клин нефрол 2010; 3: 56-61

4. Мухин НА, Козловская ЛВ. Мембранозная нефропатия: как дифференцировать первичный и вторичный варианты. Клин нефрол 2009; 2: 75-78

5. Смирнов АВ. Лечение гломерулопатий циклоспорином: правильный подход с неверным обоснованием. Нефрология 2010; 14 (4): 9-22

6. Смирнов АВ. Практические вопросы применения циклоспорина в лечении гломерулопатий. Нефрология 2010; 14 (4): 96-102

7. Beck LH, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Eng J Med 2009; 361:11-21

8. Beck LH, Fervenza FC, Beck DM et al. Rituximab-induced depletion of anti-PLAjR autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1543-1550

9. Bomback AS, Derebail VK, McGregor JG. Rituximab therapy for membranous nephropathy. Clin J Am Soc Nephol 2009; 4: 734-744

10. Branten AJ. Mycophenolate mofetil in idiopathic membranous nephropathy. Clinical trial with comparison to a historical control group treated with cyclophosphamide. Am J Kidney Dis 2007; 50: 248-256

11. Cattran DC. Cyclosporin in idiopathic glomerular disease associated with the nephritic syndrome: workshop recommendations. Kidney Int 2007; 72(12): 1429-1447

12. Cattran DC. North America nephrotic syndrome study G: Cyclosporin in patients with steroid resistant membranous nephropathy: a randomize trial. J Am Soc Nephrol 2001; 59: 1484-1490

13. Cattran DC. Management of Idiopathic membranous nephropathy. What and When for treatment. J Am Soc Nephrol 2005; 16: 1188-1194

14. Debeick H, Lefeu F, Kemper MJ et al. Early childhood membranous nephropathy induced by antibodies to cationic bovine serum albumin. N Eng J Med 2011; 364: 2101-2110

15. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010; 38: 157-167

16. Glassock R.J. Diagnosis and natural course of membranous nephropathy. Sem Nephrol. 2003; 23: 324-332.

17. Kidney Diseases: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for glomerulonephritis. Kidney Int Suppl 2012; 2(2):139-274

18. Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20(3): 268-287

19. Ronco P, Debeic H. Advances in membranous nephropathy: success stories of a long journey. Clin and Experiment Pharmacol and Physiol 2011; 38: 410-416